Coupling and uncoupling of tumor immunity and autoimmunity

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Self-antigens like differentiation antigens are recognized on cancers, including melanoma.
• Previous studies showed active immunization against gp75 (TRP-1) induced tumor immunity and autoimmunity via autoantibodies.
• Tyrosinase-related protein 2 (TRP-2) is another melanocyte differentiation antigen expressed by melanomas.

Purpose of the Study:

• To characterize the immune response against TRP-2 using a mouse model.
• To compare the mechanisms of tumor immunity and autoimmunity induced by TRP-1 and TRP-2.
• To investigate the roles of CD4(+) cells, CD8(+) T cells, antibodies, and perforin in TRP-2 immunity.

Main Methods:

• DNA immunization against xenogeneic TRP-2 in mice.
• Assessment of tumor immunity and autoimmunity.
• Analysis of immune cell involvement (CD4(+), CD8(+)) and antibody production.
• Evaluation of perforin's role in tumor immunity and autoimmunity.

Main Results:

• DNA immunization against xenogeneic TRP-2 induced tumor immunity and autoimmunity, dependent on CD4(+) cells.
• TRP-2 immunization generated autoantibodies and autoreactive cytotoxic T cells.
• Both tumor immunity and autoimmunity against TRP-2 required CD8(+) T cells, unlike TRP-1 immunity which was antibody-mediated.
• Autoimmunity against TRP-2 required perforin, while tumor immunity did not.
• Immunity against TRP-1 and TRP-2 involved different mechanisms but resulted in similar autoimmune manifestations.

Conclusions:

• Immunity against closely related autoantigens (TRP-1 and TRP-2) can be mediated by distinct immune mechanisms (antibody vs. CD8(+) T cell).
• Both pathways effectively induce tumor immunity and lead to comparable autoimmune phenotypes.
• Understanding these distinct mechanisms is crucial for developing targeted cancer immunotherapies.